CN Patent

CN101137653A — 作为mglur5拮抗剂的噻唑-4-甲酰胺衍生物

Assigned to F Hoffmann La Roche AG · Expires 2008-03-05 · 18y expired

What this patent protects

本发明涉及新型通式(I)的噻唑－4－甲酰胺衍生物及其制备方法，所述化合物可用作代谢型谷氨酸受体拮抗剂，其中R 1 至R 4 如说明书所定义。

USPTO Abstract

本发明涉及新型通式(I)的噻唑－4－甲酰胺衍生物及其制备方法，所述化合物可用作代谢型谷氨酸受体拮抗剂，其中R 1 至R 4 如说明书所定义。

Drugs covered by this patent

Patent Metadata

Patent number
CN101137653A
Jurisdiction
CN
Classification
—
Expires
2008-03-05
Drug substance claim
No
Drug product claim
No
Assignee
F Hoffmann La Roche AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.